Therapeutic Advances in Neurological Disorders (Feb 2021)
Should ocrelizumab be used in non-active primary progressive multiple sclerosis? Time for a re-assessment
Abstract
No abstracts available.
Therapeutic Advances in Neurological Disorders (Feb 2021)